Work

Abstract B033: Petosemtamab (MCLA-158) monotherapy or with chemotherapy in metastatic colorectal cancer: Preliminary antitumor activity and safety data from a phase 2 trial

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-b033

Authors: Moh'd Khushman, Ruth Vera, Thibault Mazard, DiSean Kendall, Maria Elena. Elez, Francesc Salva, Elisa Fontana, Gregory P. Botta, Marcos Melián, Leon Pappas, Ludovic Evesque, Anastasia Murat, Chris Yan, Marina Magin, Gianluca Laus, Fabian Zohren, Josep Tabernero

Institutions: Washington University in St. Louis, Navarre Institute of Health Research, Institut Regional du Cancer de Montpellier, Utah Cancer Specialists, Vall d'Hebron Institute of Oncology, Sarah Cannon Research Institute, University of California San Diego, Fundación Instituto Valenciano de Oncología, Massachusetts General Hospital, Centre Antoine Lacassagne, Merus (Netherlands)

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444327

Cites:

Cited by: 6

Related to: